197 related articles for article (PubMed ID: 1285399)
21. Inhibition of noradrenaline release in the rat vena cava via prostanoid receptors of the EP3-subtype.
Molderings G; Malinowska B; Schlicker E
Br J Pharmacol; 1992 Oct; 107(2):352-5. PubMed ID: 1330175
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the inhibitory prostanoid receptors on human neutrophils.
Wheeldon A; Vardey CJ
Br J Pharmacol; 1993 Apr; 108(4):1051-4. PubMed ID: 8387383
[TBL] [Abstract][Full Text] [Related]
23. Characterization of EP-receptor subtypes involved in allodynia and hyperalgesia induced by intrathecal administration of prostaglandin E2 to mice.
Minami T; Nishihara I; Uda R; Ito S; Hyodo M; Hayaishi O
Br J Pharmacol; 1994 Jul; 112(3):735-40. PubMed ID: 7921597
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the prostaglandin E2 sensitive (EP)-receptor in the rat isolated trachea.
Lydford SJ; McKechnie K
Br J Pharmacol; 1994 May; 112(1):133-6. PubMed ID: 8032634
[TBL] [Abstract][Full Text] [Related]
25. Evidence for the presence of AH 13205-sensitive EP2-prostanoid receptors in the pregnant baboon but not in the pregnant sheep myometrium near term.
Garcia-Villar R; Green LR; Jenkins SL; Wentworth RA; Coleman RA; Nathanielsz PW
J Soc Gynecol Investig; 1995; 2(1):6-12. PubMed ID: 9420841
[TBL] [Abstract][Full Text] [Related]
26. Involvement of EP3 subtype of prostaglandin E receptors in PGE2-induced enhancement of the bradykinin response of nociceptors.
Kumazawa T; Mizumura K; Koda H
Brain Res; 1993 Dec; 632(1-2):321-4. PubMed ID: 8149238
[TBL] [Abstract][Full Text] [Related]
27. Characterization of the PGE receptor subtype mediating inhibition of superoxide production in human neutrophils.
Talpain E; Armstrong RA; Coleman RA; Vardey CJ
Br J Pharmacol; 1995 Apr; 114(7):1459-65. PubMed ID: 7606349
[TBL] [Abstract][Full Text] [Related]
28. Prostaglandin E2 suppression of acetylcholine release from parasympathetic nerves innervating guinea-pig trachea by interacting with prostanoid receptors of the EP3-subtype.
Spicuzza L; Giembycz MA; Barnes PJ; Belvisi MG
Br J Pharmacol; 1998 Mar; 123(6):1246-52. PubMed ID: 9559911
[TBL] [Abstract][Full Text] [Related]
29. Effects of gestational age on prostaglandin EP receptor expression and functional involvement during in vitro contraction of the guinea pig uterus.
Terry KK; Lebel WS; Riccardi KA; Grasser WA; Thompson DD; Paralkar VM
Prostaglandins Leukot Essent Fatty Acids; 2008 Jan; 78(1):3-10. PubMed ID: 18036799
[TBL] [Abstract][Full Text] [Related]
30. Prostaglandin E2 activates phospholipase C and elevates intracellular calcium in cultured myometrial cells: involvement of EP1 and EP3 receptor subtypes.
Asbóth G; Phaneuf S; Europe-Finner GN; Tóth M; Bernal AL
Endocrinology; 1996 Jun; 137(6):2572-9. PubMed ID: 8641211
[TBL] [Abstract][Full Text] [Related]
31. The roles of prostaglandin E receptor subtypes in the cytoprotective action of prostaglandin E2 in rat stomach.
Araki H; Ukawa H; Sugawa Y; Yagi K; Suzuki K; Takeuchi K
Aliment Pharmacol Ther; 2000 Apr; 14 Suppl 1():116-24. PubMed ID: 10807413
[TBL] [Abstract][Full Text] [Related]
32. Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor subtypes.
Boie Y; Stocco R; Sawyer N; Slipetz DM; Ungrin MD; Neuschäfer-Rube F; Püschel GP; Metters KM; Abramovitz M
Eur J Pharmacol; 1997 Dec; 340(2-3):227-41. PubMed ID: 9537820
[TBL] [Abstract][Full Text] [Related]
33. EP receptor subtypes implicated in the PGE2-induced sensitization of polymodal receptors in response to bradykinin and heat.
Kumazawa T; Mizumura K; Koda H; Fukusako H
J Neurophysiol; 1996 Jun; 75(6):2361-8. PubMed ID: 8793749
[TBL] [Abstract][Full Text] [Related]
34. EP1- and EP3-receptors mediate prostaglandin E2-induced constriction of porcine large cerebral arteries.
Jadhav V; Jabre A; Lin SZ; Lee TJ
J Cereb Blood Flow Metab; 2004 Dec; 24(12):1305-16. PubMed ID: 15625406
[TBL] [Abstract][Full Text] [Related]
35. Modulation of noradrenaline release from the sympathetic nerves of the human saphenous vein and pulmonary artery by presynaptic EP3- and DP-receptors.
Molderings GJ; Colling E; Likungu J; Jakschik J; Göthert M
Br J Pharmacol; 1994 Mar; 111(3):733-8. PubMed ID: 8019753
[TBL] [Abstract][Full Text] [Related]
36. Prostanoid-induced inhibition of lipolysis in rat isolated adipocytes: probable involvement of EP3 receptors.
Strong P; Coleman RA; Humphrey PP
Prostaglandins; 1992 Jun; 43(6):559-66. PubMed ID: 1410520
[TBL] [Abstract][Full Text] [Related]
37. Prostaglandin E potentiates the immunologically stimulated histamine release from human peripheral blood-derived mast cells through EP1/EP3 receptors.
Wang XS; Lau HY
Allergy; 2006 Apr; 61(4):503-6. PubMed ID: 16512814
[TBL] [Abstract][Full Text] [Related]
38. SC-46275: a potent and highly selective agonist at the EP3 receptor.
Savage MA; Moummi C; Karabatsos PJ; Lanthorn TH
Prostaglandins Leukot Essent Fatty Acids; 1993 Dec; 49(6):939-43. PubMed ID: 8140121
[TBL] [Abstract][Full Text] [Related]
39. Prostaglandin E2 inhibits mast cell-dependent bronchoconstriction in human small airways through the E prostanoid subtype 2 receptor.
Säfholm J; Manson ML; Bood J; Delin I; Orre AC; Bergman P; Al-Ameri M; Dahlén SE; Adner M
J Allergy Clin Immunol; 2015 Nov; 136(5):1232-9.e1. PubMed ID: 25962903
[TBL] [Abstract][Full Text] [Related]
40. Human granulosa-lutein cells express functional EP1 and EP2 prostaglandin receptors.
Harris TE; Squires PE; Michael AE; Bernal AL; Abayasekara DR
Biochem Biophys Res Commun; 2001 Aug; 285(5):1089-94. PubMed ID: 11478765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
